Skip to content
value.today
Protalix BioTherapeutics, Inc. logo

Protalix BioTherapeutics, Inc.

PLX.TA
$59 Mlast known market cap, Dec 2022 — no current value
Compare
World rank
—
no current market cap
Revenue
$53 M
For year ending December-2025
value.today research
Net income
$-7 M
-12.5% margin
value.today research
Employees
226
As of December 31, 2025
value.today research

Protalix BioTherapeutics, Inc. in brief

Protalix BioTherapeutics, Inc. is a listed company in the Biotechnology industry, based in Israel. It was founded in 1993. Its last known market value was $59 M (December 2022); there is no current figure. In the year to December 2025 it had sales of $53 M and a net loss of $7 M. It employs about 226 people. Its shares trade under the symbol PLX.TA (Tel Aviv).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Protalix BioTherapeutics, Inc.

Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease.

From Wikipedia: read the full article · text available under CC BY-SA 4.0

Protalix BioTherapeutics, Inc. timeline

2 events, 1993–2016
  1. 1993
  2. 🏁
    · approximate
    Founded by Joseph Chaaltiel
  3. 2016
  4. •
    Legal Entity Identifier issued
    LEI 549300SDVB3GP4XDFM60 registered.

Events of Protalix BioTherapeutics, Inc. from Wikidata and the GLEIF LEI register. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$33 M$65 M$98 M$131 M202020212022

World rank over time

▼ down 2,845 places since 2020
2020-01-01: #21572#21,57220202021-01-01: #17478#17,47820212022-01-07: #27430#27,43020222022-12-25: #24417#24,4172022

Rank in Israel: #267 (Jan 2020) · #207 (Jan 2021) · #399 (Jan 2022) · #290 (Dec 2022)

Key ratios

market cap and latest results
P/E ratio
n/m (loss)
Price / sales
—
Price / book
—
Free cash flow yield
—
Net margin
-12.5%
Operating margin
-10.4%
Return on equity
-13.7%
Liabilities / assets
41.4%
Revenue per employee
$233 K
Profit per employee
$-29 K

Annual results

Revenue
$53 M
Operating income
$-6 M
Net income
$-7 M

For year ending December-2025

Balance sheet

Total assets
$82 M
Total liabilities
$34 M
Total equity
$48 M

As of December-2025

Top 100 institutional investors in Protalix BioTherapeutics, Inc.#

As of Sep 30, 2026
107 institutions held 15.9 M shares on Sep 30, 2026. Source: SEC Form 13F filings, filed through Nov 17, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 25 largest institutional investors in Protalix BioTherapeutics, Inc.
#InstitutionShares heldChange (shares)ValueFiled
1BlackRock, Inc.4,200,737+154,087 (+3.81%)$12 MNov 13, 2026
2State Street Corp1,157,119+173,537 (+17.64%)$3 MNov 12, 2026
3Geode Capital Management, LLC997,128+17,133 (+1.75%)$3 MNov 6, 2026
4Renaissance Technologies LLC988,100-107,900 (-9.84%)$3 MNov 12, 2026
5Goldman Sachs Group Inc889,350+413,428 (+86.87%)$2 MNov 16, 2026
6Northern Trust Corp831,726-90,614 (-9.82%)$2 MNov 16, 2026
7Dimensional Fund Advisors LP716,986+223,562 (+45.31%)$2 MNov 4, 2026
8Vanguard Portfolio Management LLC557,199+46,560 (+9.12%)$2 MNov 13, 2026
9Stratos Wealth Partners, LTD.400,000-100,000 (-20.00%)$1 MNov 13, 2026
10Creative Planning375,359New$1 MNov 2, 2026
11Strs Ohio332,500+36,400 (+12.29%)$1 MOct 30, 2026
12Acadian Asset Management LLC331,946New$1 MNov 9, 2026
13Marshall Wace, LLP301,768-150,989 (-33.35%)$1 MNov 13, 2026
14Citadel Advisors LLC281,229-52,998 (-15.86%)$1 MNov 16, 2026
15Lazard Asset Management LLC269,900+104,339 (+63.02%)$1 MNov 16, 2026
16Russell Investments Group, Ltd.248,557+223,792 (+903.66%)$1 MNov 6, 2026
17Bank of New York Mellon Corp231,814-1,178 (-0.51%)$1 MNov 5, 2026
18Charles Schwab Investment Management Inc194,228+13,847 (+7.68%)$1 MNov 16, 2026
19Arrowstreet Capital, Limited Partnership163,881New$0 MNov 13, 2026
20Bridgeway Capital Management, LLC157,444-31,656 (-16.74%)$0 MNov 16, 2026
21Concurrent Investment Advisors, LLC126,314New$0 MOct 16, 2026
22Bank Of America Corp /de/115,339+63,443 (+122.25%)$0 MNov 16, 2026
23Nuveen, LLC98,593+8,405 (+9.32%)$0 MNov 10, 2026
24Empowered Funds, LLC98,344New$0 MNov 13, 2026
25Morgan Stanley97,585+45,909 (+88.84%)$0 MNov 13, 2026
Show all 100: investors 26 to 100
Institutional investors 26 to 100 in Protalix BioTherapeutics, Inc.
#InstitutionShares heldChange (shares)ValueFiled
26Quadrature Capital Ltd77,751New$0 MNov 13, 2026
27Vanguard Fiduciary Trust Co73,495+3,218 (+4.58%)$0 MNov 13, 2026
28Prudential Financial Inc73,490+63,380 (+626.90%)$0 MNov 16, 2026
29Walleye Capital LLC70,533+50,694 (+255.53%)$0 MNov 13, 2026
30Deutsche Bank AG\67,954-9,583 (-12.36%)$0 MNov 6, 2026
31XTX Topco Ltd63,201New$0 MNov 16, 2026
32AQR Capital Management LLC62,518-105,308 (-62.75%)$0 MNov 16, 2026
33Bailard, Inc.61,1000 (0.00%)$0 MOct 13, 2026
34WINTON GROUP Ltd54,403-1,598 (-2.85%)$0 MNov 12, 2026
35Price T Rowe Associates Inc /MD/53,4780 (0.00%)$0 MNov 16, 2026
36Rhumbline Advisers47,580+1,356 (+2.93%)$0 MNov 10, 2026
37MetLife Investment Management, LLC45,5000 (0.00%)$0 MNov 16, 2026
38Public Employees Retirement System Of Ohio41,225New$0 MNov 16, 2026
39Two Sigma Investments, LP40,273-2,242 (-5.27%)$0 MNov 16, 2026
40Jpmorgan Chase & Co40,133-92,858 (-69.82%)$0 MNov 12, 2026
41Franklin Templeton Inc39,077-2,237 (-5.41%)$0 MNov 12, 2026
42Invesco Ltd.39,053+2,337 (+6.37%)$0 MNov 12, 2026
43Two Sigma Securities, LLC38,286+20,491 (+115.15%)$0 MNov 16, 2026
44Cambridge Investment Research Advisors, Inc.37,812New$0 MNov 2, 2026
45MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.35,928+1,831 (+5.37%)$0 MNov 16, 2026
46Gsa Capital Partners LLP35,183New$0 MNov 16, 2026
47Barclays PLC31,938+20,448 (+177.96%)$0 MNov 6, 2026
48New York State Common Retirement Fund31,1000 (0.00%)$0 MNov 17, 2026
49Bolton Securities Corporation31,0600 (0.00%)$0 MNov 12, 2026
50James River Asset Management LLC30,0000 (0.00%)$0 MNov 16, 2026
51Aptus Capital Advisors, LLC28,612+646 (+2.31%)$0 MNov 13, 2026
52Earned Wealth Advisors, LLC25,9750 (0.00%)$0 MNov 6, 2026
53Smartleaf Asset Management LLC25,9750 (0.00%)$0 MNov 10, 2026
54Wells Fargo & Company/mn24,193-43,356 (-64.18%)$0 MNov 16, 2026
55Alliancebernstein L.P.24,1600 (0.00%)$0 MNov 16, 2026
56Susquehanna International Group, LLP23,383-17,561 (-42.89%)$0 MNov 16, 2026
57State of Alaska, Department of Revenue21,8310 (0.00%)$0 MOct 15, 2026
58BNP Paribas Financial Markets20,730+8,066 (+63.69%)$0 MNov 12, 2026
59Royal Bank Of Canada19,603+9,949 (+103.06%)$0 MNov 16, 2026
60Commonwealth Equity Services, LLC19,4610 (0.00%)$0 MNov 2, 2026
61Police & Firemen's Retirement System of New Jersey18,5540 (0.00%)$0 MNov 9, 2026
62Voya Investment Management LLC16,634+5,917 (+55.21%)$0 MNov 10, 2026
63Ashton Thomas Private Wealth, LLC15,828New$0 MNov 3, 2026
64Lido Advisors, LLC15,554-6 (-0.04%)$0 MNov 4, 2026
65American Century Companies Inc15,523New$0 MNov 12, 2026
66Prelude Capital Management, LLC14,200-8,500 (-37.44%)$0 MNov 16, 2026
67Equitable Holdings, Inc.13,1500 (0.00%)$0 MNov 16, 2026
68Point72 Asset Management, L.P.13,027-12,539 (-49.05%)$0 MNov 16, 2026
69UBS Group AG12,741-125,905 (-90.81%)$0 MNov 10, 2026
70Spark Investment Management LLC11,800New$0 MNov 13, 2026
71Orin Green Financial, LLC10,675+675 (+6.75%)$0 MOct 19, 2026
72Harbour Investment Management LLC10,1000 (0.00%)$0 MNov 16, 2026
73Kestra Advisory Services, LLC10,0000 (0.00%)$0 MNov 2, 2026
74Legal & General Group Plc7,826+1,493 (+23.57%)$0 MNov 16, 2026
75Altshuler Shaham Ltd7,7420 (0.00%)$0 MNov 12, 2026
76Ameritas Investment Partners, Inc.7,1190 (0.00%)$0 MNov 13, 2026
77Harbour Investments, Inc.6,0000 (0.00%)$0 MNov 9, 2026
78TD Waterhouse Canada Inc.6,0000 (0.00%)$0 MOct 16, 2026
79Simplex Trading, LLC4,891-20,157 (-80.47%)$0 MNov 4, 2026
80Tower Research Capital LLC (TRC)4,065-4,604 (-53.11%)$0 MNov 16, 2026
81Citigroup Inc3,941-30,748 (-88.64%)$0 MNov 4, 2026
82Fortitude Family Office, LLC3,225New$0 MOct 14, 2026
83FMR LLC3,010+21 (+0.70%)$0 MNov 10, 2026
84Sterling Capital Management LLC2,429+2,169 (+834.23%)$0 MOct 22, 2026
85Federation des caisses Desjardins du Quebec2,300+2,050 (+820.00%)$0 MNov 16, 2026
86National Bank Of Canada /fi/2,0000 (0.00%)$0 MNov 16, 2026
87California State Teachers Retirement System1,0200 (0.00%)$0 MNov 13, 2026
88Investment Research & Advisory Group, Inc.1,0000 (0.00%)$0 MOct 19, 2026
89Farther Finance Advisors, LLC986+878 (+812.96%)$0 MOct 8, 2026
90Geneos Wealth Management Inc.8000 (0.00%)$0 MNov 9, 2026
91GAMMA Investing LLC627+272 (+76.62%)$0 MOct 8, 2026
92Arax Advisory Partners361-751 (-67.54%)$0 MNov 12, 2026
93Pinnacle Financial Group, Inc.350—$0 MNov 16, 2026
94Vanguard Global Advisers, LLC336New$0 MNov 13, 2026
95Allworth Financial LP301-3 (-0.99%)$0 MNov 17, 2026
96Osaic Holdings, Inc.3000 (0.00%)$0 MNov 12, 2026
97Activest Wealth Management3000 (0.00%)$0 MOct 15, 2026
98PNC Financial Services Group, Inc.293+273 (+1365.00%)$0 MNov 6, 2026
99Global Retirement Partners, LLC246New$0 MNov 10, 2026
100Y.D. More Investments Ltd2200 (0.00%)$0 MNov 2, 2026

All 107 institutional investors, with who bought and sold →

Mutual funds holding Protalix BioTherapeutics, Inc.#

71 funds hold shares worth $14 M. Since their previous reports 38 added shares and 14 sold, buying $2 M net.
Mutual funds holding Protalix BioTherapeutics, Inc.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors1.93 M$5 M—<0.01%+15%Jun 30, 2026
🇺🇸 Fidelity Small Cap Index FundFidelity Management & Research Company LLC802,533$2 M—<0.01%+11%Jul 31, 2026
🇺🇸 iShares Russell 2000 Growth ETFBlackRock Fund Advisors695,410$2 M—0.01%+13%Jun 30, 2026
🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc.372,499$1 M—<0.01%+4.5%May 31, 2026
🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors248,807$1 M—0.04%+35%Jun 30, 2026
🇺🇸 Dimensional U.S. Small Cap ETFDimensional Fund Advisors LP215,985$1 M—<0.01%−18%Jul 31, 2026
🇺🇸 Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc.180,314$0 M—<0.01%+13%Jul 31, 2026
🇺🇸 Ultra-Small Company Market FundBridgeway Capital Management, LLC180,000$0 M—0.28%no changeJun 30, 2026
🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC120,799$0 M—<0.01%no changeJun 30, 2026
🇺🇸 Nuveen Small Cap Blend Index FundTeachers Advisors, LLC90,188$0 M—<0.01%no changeJul 31, 2026
🇺🇸 U.S. Micro Cap PortfolioDimensional Fund Advisors LP87,615$0 M—<0.01%+223%Jul 31, 2026
🇺🇸 U.S. Small Cap Equity FundRussell Investment Management, LLC80,374$0 M—0.02%newJul 31, 2026
🇺🇸 WisdomTree U.S. SmallCap FundWisdomTree Asset Management, Inc.78,247$0 M—0.03%−2.3%Jun 30, 2026
🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC75,469$0 M—<0.01%no changeJun 30, 2026
🇺🇸 Fidelity Small Cap Growth Index FundFidelity Management & Research Company LLC69,173$0 M—0.01%+24%Jun 30, 2026
🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P.66,396$0 M—<0.01%−16%Jun 30, 2026
🇺🇸 Nationwide Bailard Small Cap Value FundNATIONWIDE FUND ADVISORS61,100$0 M—0.11%newJul 31, 2026
🇺🇸 Vanguard Russell 2000 Growth Index FundThe Vanguard Group, Inc.67,740$0 M—<0.01%+3.1%May 31, 2026
🇺🇸 LVIP State Street Small-Cap Index FundLincoln Financial Investments Corporation50,400$0 M—<0.01%no changeJun 30, 2026
🇺🇸 Goldman Sachs Small Cap Growth Insights FundGoldman Sachs Asset Management, L.P.42,020$0 M—0.03%newJul 31, 2026
🇺🇸 Venerable US Small Cap FundVenerable Investment Advisers, LLC41,314$0 M—0.06%newJun 30, 2026
🇺🇸 Global X Russell 2000 ETFGlobal X Management Company LLC35,366$0 M—<0.01%+12%Jul 31, 2026
🇺🇸 Small Cap Index FundNorthern Trust Investments, Inc.32,575$0 M—<0.01%−17%Jun 30, 2026
🇺🇸 U.S. Small Cap PortfolioDimensional Fund Advisors LP29,948$0 M—<0.01%+19%Jul 31, 2026
🇺🇸 State Street Small/mid Cap Equity Index PortfolioSSGA Funds Management, Inc.27,900$0 M—<0.01%no changeJun 30, 2026
🇺🇸 Dimensional U.S. Targeted Value ETFDimensional Fund Advisors LP27,186$0 M—<0.01%newJul 31, 2026
🇺🇸 U.S. Sustainability Targeted Value PortfolioDimensional Fund Advisors LP26,778$0 M—<0.01%newJul 31, 2026
🇺🇸 MetLife Russell 2000 Index PortfolioBrighthouse Investment Advisers, LLC27,091$0 M—<0.01%+7.1%Jun 30, 2026
🇺🇸 Small Cap Index FundThe Variable Annuity Life Insurance Company29,103$0 M—<0.01%no changeMay 31, 2026
🇺🇸 U.S. Targeted Value PortfolioDimensional Fund Advisors LP22,270$0 M—<0.01%newJul 31, 2026
🇺🇸 NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS19,387$0 M—<0.01%+49%Jun 30, 2026
🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC18,218$0 M—<0.01%no changeJun 30, 2026
🇺🇸 Goldman Sachs Variable Insurance Trust Small Cap Equity Insights FundGoldman Sachs Asset Management, L.P.17,147$0 M—0.02%newJun 30, 2026
🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC16,684$0 M—0.02%+28%Jun 30, 2026
🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC15,471$0 M—<0.01%no changeJun 30, 2026
🇺🇸 U.S. Vector Equity PortfolioDimensional Fund Advisors LP14,721$0 M—<0.01%newJul 31, 2026
🇺🇸 Bridge Builder Small/Mid Cap Growth FundOLIVE STREET INVESTMENT ADVISERS LLC13,641$0 M—<0.01%no changeJun 30, 2026
🇺🇸 iShares Russell Small/Mid-Cap Index FundBlackRock Advisors, LLC12,426$0 M—<0.01%no changeJul 31, 2026
🇺🇸 EQ/Morgan Stanley Small Cap Growth PortfolioEquitable Investment Management Group, LLC12,179$0 M—<0.01%+36%Jun 30, 2026
🇺🇸 EQ/AB Small Cap Growth PortfolioEquitable Investment Management Group, LLC12,080$0 M—<0.01%+106%Jun 30, 2026
🇺🇸 EQ/Small Company Index PortfolioEquitable Investment Management Group, LLC12,080$0 M—<0.01%+106%Jun 30, 2026
🇺🇸 Voya RussellTM Small Cap Index PortfolioVoya Investments, LLC10,717$0 M—<0.01%+50%Jun 30, 2026
🇺🇸 DWS Small Cap Index VIPDWS Investment Management Americas, Inc.10,693$0 M—<0.01%no changeJun 30, 2026
🇺🇸 Dimensional US Core Equity 1 ETFDimensional Fund Advisors LP10,500$0 M—<0.01%newJul 31, 2026
🇺🇸 Dimensional U.S. Core Equity 2 ETFDimensional Fund Advisors LP10,251$0 M—<0.01%no changeJul 31, 2026
🇺🇸 T. Rowe Price Small-Cap Index FundT. Rowe Price Associates, Inc.10,063$0 M—<0.01%no changeJun 30, 2026
🇺🇸 Dimensional US Small Cap Value ETFDimensional Fund Advisors LP9,700$0 M—<0.01%newJul 31, 2026
🇺🇸 Siit Extended Market Index FundSEI INVESTMENTS MANAGEMENT CORPORATION10,200$0 M—<0.01%no changeMay 31, 2026
🇺🇸 Victory Extended Market Index FundVictory Capital Management Inc.8,951$0 M—<0.01%+8.7%Jul 31, 2026
🇺🇸 BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC8,740$0 M—<0.01%no changeJun 30, 2026
🇺🇸 SA Small Cap Index PortfolioSunAmerica Asset Management, LLC7,779$0 M—<0.01%no changeJul 31, 2026
🇺🇸 PD Small-Cap Growth Index PortfolioPacific Life Fund Advisors LLC7,125$0 M—0.01%+39%Jun 30, 2026
🇺🇸 CVT Russell 2000 Small Cap Index PortfolioCalvert Research and Management7,119$0 M—<0.01%no changeJun 30, 2026
🇺🇸 JNL/DFA U.S. Small Cap FundJackson National Asset Management, LLC6,742$0 M—<0.01%no changeJun 30, 2026
🇺🇸 SmallCap Growth Fund IPrincipal Global Investors, LLC6,389$0 M—<0.01%+18%Jul 31, 2026
🇺🇸 Nationwide Fundamental All Cap Equity PortfolioNATIONWIDE FUND ADVISORS6,121$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Nationwide Small Cap Index FundNATIONWIDE FUND ADVISORS5,979$0 M—<0.01%no changeJul 31, 2026
🇺🇸 U.S. Small Cap Value PortfolioDimensional Fund Advisors LP5,800$0 M—<0.01%newJul 31, 2026
🇺🇸 Dimensional VA U.S. Targeted Value PortfolioDimensional Fund Advisors LP5,738$0 M—<0.01%newJul 31, 2026
🇺🇸 Venerable Small Cap Index FundVenerable Investment Advisers, LLC5,776$0 M—<0.01%no changeJun 30, 2026
🇺🇸 Vanguard Russell 3000 Index FundThe Vanguard Group, Inc.5,525$0 M—<0.01%no changeMay 31, 2026
🇺🇸 U.S. Social Core Equity 2 PortfolioDimensional Fund Advisors LP4,900$0 M—<0.01%newJul 31, 2026
🇺🇸 U.S. Small Cap Growth PortfolioDimensional Fund Advisors LP4,774$0 M—<0.01%no changeJul 31, 2026
🇺🇸 ProShares Russell 2000 High Income ETFPROSHARE ADVISORS LLC3,439$0 M—<0.01%+9.9%May 31, 2026
🇺🇸 EQ/Franklin Small Cap Value Managed Volatility PortfolioEquitable Investment Management Group, LLC2,983$0 M—<0.01%no changeJun 30, 2026
🇺🇸 ProShares Ultra Russell2000PROSHARE ADVISORS LLC2,688$0 M—<0.01%−40%May 31, 2026
🇺🇸 ProShares UltraPro Russell2000PROSHARE ADVISORS LLC2,718$0 M—<0.01%−39%May 31, 2026
🇺🇸 Destinations Small-Mid Cap Equity FundBrinker Capital Investments, LLC2,547$0 M—<0.01%no changeMay 31, 2026
🇺🇸 State Street Total Return V.I.S. FundSSGA Funds Management, Inc.1,735$0 M—<0.01%no changeJun 30, 2026
🇺🇸 Total Stock Market Index TrustJohn Hancock Variable Trust Advisers LLC1,542$0 M—<0.01%newJun 30, 2026
🇺🇸 Blackstone Alternative Multi-Strategy FundBlackstone Alternative Investment Advisors LLC200$0 M—<0.01%newJun 30, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 71 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Where Protalix BioTherapeutics, Inc. operates: 2 countries#

Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue.

Protalix BioTherapeutics, Inc.: countries of operation
CountryPresenceRevenue there
🇮🇱 IsraelHeadquarters2 offices—
🇺🇸 USA1 office—

Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided

How Protalix BioTherapeutics, Inc. compares in Biotechnology

  • Revenue$53 M · higher than 60% of 647
  • Net margin-12.5% · higher than 64% of 408

Peer comparison · Biotechnology

CompanyMarket capP/ENet marginRev. growth
Protalix BioTherapeutics, Inc.🇮🇱$59 M—-12.5%—
Novo Nordisk A/S🇩🇰$203.2 B13.1×33.1%+10.8%
Vertex Pharmaceuticals Incorporated🇺🇸$134.3 B33.8×30.7%+8.9%
Moderna, Inc.🇺🇸$90.1 B—-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.🇺🇸$84.1 B17.5×28.5%+1.0%
Argenx SE🇳🇱$52.8 B40.9×31.1%+89.9%
CSL Limited🇦🇺$51.6 B—-16.4%—
Samsung Biologics Co., Ltd.🇰🇷$51.5 B40.5×39.2%—
UCB SA🇧🇪$48.6 B26.3×20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Dec 25, 2022 (last known)
Annual results:
For year ending December-2025
Balance sheet:
As of December-2025
Employees:
As of December 31, 2025
Profile updated:
Nov 15, 2026

Figures from value.today research, Wikidata, Wikipedia, GLEIF register.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Protalix BioTherapeutics, Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Protalix BioTherapeutics, Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Protalix BioTherapeutics, Inc.? Suggest a correction